The Form 4 filing, a public report of an insider’s stock trades, was submitted on Nov. 12, 2026. That was two days after the sale by Brian J. Caveney, an executive vice president at Labcorp Holdings.
The company is listed in the healthcare sector, under diagnostics and research.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 2,000 |
| Price | $372.04 |
| Total Transaction Value | $744,080.20 |
| Insider | |
| Ticker Symbol | LH |
| Company | LABCORP HOLDINGS INC. |
| Insider Name | Caveney Brian J |
| Insider Title | EVP, Pres of BLS, CMO & CSO |
| Sector - Industry | Healthcare - Diagnostics & Research |
| Holdings | |
| Total Shares Owned After Transaction | 34,562.05 |
| Position Size Change | 5.47% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Labcorp Holdings (LH) shares, reported with transaction code S. The report lists one transaction on Nov. 10, 2026.
What was the average price of the transaction?
The reported average price was $372.0401 per share. Rounded to the nearest cent, that is $372.04 per share.
How did this transaction affect the insider's holdings?
Brian J. Caveney sold 2,000 shares, equal to 5.47% of his reported shares before the sale. He reported owning 34,562.0463 shares afterward. That remaining balance rounds to 34,562.05 shares in the transaction details.
What's the total transaction value?
The total transaction value was $744,080.20 for the single reported sale of 2,000 shares.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnotes were unavailable for this report, so further details about the sale’s terms remain unknown.
For research purposes only; not investment advice.